Abstract:figure legend Auditory outer hair cells are the cochlear amplifier essential for normal hearing sensitivity and frequency selectivity. This study used both cell lines and a mouse model to define the pathogenic role of compound heterozygous p.W70X (c.209G>A) and p.R130S (c.390A>C) SLC26A5 variants identified in patients with moderate to profound hearing loss. We found that the p.W70X nonsense variant results in a null prestin allele, and that mice carrying one copy of p.R130S (Slc26a5R130S/‐) as in human patients (SLC26A5W70X/R130S) suffer from congenital hearing loss and subsequent premature outer hair cell loss. The latter are both ascribed to slowed motor function of p.R130S prestin, as demonstrated in our preceding studies. Given the recessive nature of prestin‐associated hearing loss, DFNB61, this study points to the presence of a therapeutic time window for potential clinical interventions targeting the affected OHCs before they are lost. DFNB61 is a recessively inherited nonsyndromic hearing loss caused by mutations in SLC26A5, the gene that encodes the voltage‐driven motor protein, prestin. Prestin is abundantly expressed in the auditory outer hair cells that mediate cochlear amplification. Two DFNB61‐associated SLC26A5 variants, p.W70X and p.R130S, were identified in patients who are compound heterozygous for these nonsense and missense changes (SLC26A5W70X/R130S). Our recent study showed that mice homozygous for p.R130S (Slc26a5R130S/R130S) suffer from hearing loss that is ascribed to significantly reduced motor kinetics of prestin. Given that W70X‐prestin is nonfunctional, compound heterozygous Slc26a5R130S/− mice were used as a model for human SLC26A5W70X/R130S. By examining the pathophysiological consequences of p.R130S prestin when it is the sole allele for prestin protein production, we determined that this missense change results in progressive outer hair cell loss in addition to its effects on prestin's motor action. Thus, this study defines the pathogenic roles of p.R130S prestin and identifies a limited time window for potential clinical intervention. Key points The voltage‐driven motor protein, prestin, is encoded by SLC26A5 and expressed abundantly in cochlear outer hair cells (OHCs). The importance of prestin for normal hearing was demonstrated in mice lacking prestin; however, none of the specific SLC26A5 variants identified to date in human patients has been experimentally demonstrated to be pathogenic. In this study we used both cell lines and a mouse model to define the pathogenic role of compound heterozygous p.W70X (c.209G>A) and p.R130S (c.390A>C) SLC26A5 variants identified in patients with moderate to profound hearing loss. As in patients, mice carrying one copy of p.R130S Slc26a5 showed OHC dysfunction and progressive degeneration, which results in congenital progressive hearing loss. This is the first functional study reporting pathogenic SLC26A5 variants and pointing to the presence of a therapeutic time window for potential clinical interventions targeting the affected OHCs before they are lost.

The pathogenic roles of the p.R130S prestin variant in DFNB61 hearing loss

The frequency dependence of prestin-mediated fast electromotility for mammalian cochlear amplification

Functional Characterization of the Mitochondrial 12S Rrna C1494T Mutation Associated with Aminoglycoside-Induced and Non-Syndromic Hearing Loss.

Mutations of Human NARS2, Encoding the Mitochondrial Asparaginyl-Trna Synthetase, Cause Nonsyndromic Deafness and Leigh Syndrome

Functional Studies of Deafness-Associated Pendrin and Prestin Variants

A Dominant Variant in the PDE1C Gene is Associated with Nonsyndromic Hearing Loss

Abnormal Mrna Splicing but Normal Auditory Brainstem Response (ABR) in Mice with the Prestin (SLC26A5) IVS2-2A>G Mutation.

A Novel PTPRQ c.3697del Variant Causes Autosomal Dominant Progressive Hearing Loss in Both Humans and Mice

Reduction in Noise-Induced Functional Loss of the Cochleae in Mice with Pre-Existing Cochlear Dysfunction Due to Genetic Interference of Prestin

Insights into phenotypic differences between humans and mice with p.T721M and other C-terminal variants of the SLC26A4 gene

Toward the Pathogenicity of the SLC26A4 p.C565Y Variant Using a Genetically Driven Mouse Model

Deletion of Exons 17 and 18 in Prestin’s STAS Domain Results in Loss of Function

Hearing Threshold Elevation Precedes Hair-Cell Loss In Prestin Knockout Mice

Identification of Novel Functional Null Allele of SLC26A4 Associated with Enlarged Vestibular Aqueduct and Its Possible Implication

A Knock-in Mouse Model of Pendred Syndrome with Slc26a4 L236P Mutation

CRISPR/Cas9-mediated exon skipping to restore premature translation termination in a DFNB4 mouse model

Evaluation of an Independent Prestin Mouse Model Derived from the 129S1 Strain

S1PR2 Variants Associated with Auditory Function in Humans and Endocochlear Potential Decline in Mouse

Novel POU3F4 variants identified in patients with inner ear malformations exhibit aberrant cellular distribution and lack of SLC6A20 transcriptional upregulation

Distinct and Novel SLC26A4/Pendrin Mutations in Chinese and U.S. Patients with Nonsyndromic Hearing Loss.